ZYNE logo

Zynerba Pharmaceuticals (ZYNE) EBITDA

Annual EBITDA

-$35.03 M
+$1.49 M+4.08%

31 December 2022

ZYNE EBITDA Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly EBITDA

-$11.07 M
-$651.00 K-6.25%

30 June 2023

ZYNE Quarterly EBITDA Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM EBITDA

-$38.56 M
-$1.96 M-5.34%

30 June 2023

ZYNE TTM EBITDA Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ZYNE EBITDA Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year---
3 y3 years+32.4%-9.1%-1.8%
5 y5 years+13.1%-485.7%-25.1%

ZYNE EBITDA High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years
5 y5 years
alltimeall time+5888.4%+4723.7%>+9999.0%

Zynerba Pharmaceuticals EBITDA History

DateAnnualQuarterlyTTM
June 2023
-
-$11.07 M(+6.2%)
-$38.56 M(+5.3%)
Mar 2023
-
-$10.42 M(+20.7%)
-$36.61 M(+4.5%)
Dec 2022
-$35.03 M(-4.1%)
-$8.63 M(+2.3%)
-$35.03 M(-0.4%)
Sept 2022
-
-$8.44 M(-7.4%)
-$35.17 M(-4.6%)
June 2022
-
-$9.11 M(+3.1%)
-$36.88 M(-1.8%)
Mar 2022
-
-$8.84 M(+0.8%)
-$37.54 M(+2.8%)
Dec 2021
-$36.52 M(-29.6%)
-$8.77 M(-13.5%)
-$36.52 M(-3.6%)
Sept 2021
-
-$10.15 M(+3.8%)
-$37.88 M(+2.6%)
June 2021
-
-$9.78 M(+25.0%)
-$36.90 M(-24.6%)
Mar 2021
-
-$7.82 M(-22.8%)
-$48.92 M(-5.7%)
Dec 2020
-$51.86 M(+51.7%)
-$10.13 M(+10.4%)
-$51.86 M(-2.4%)
Sept 2020
-
-$9.17 M(-57.9%)
-$53.11 M(+15.9%)
June 2020
-
-$21.79 M(+102.6%)
-$45.82 M(+29.1%)
Mar 2020
-
-$10.76 M(-5.5%)
-$35.51 M(+3.9%)
Dec 2019
-$34.19 M(-15.2%)
-$11.38 M(+502.1%)
-$34.19 M(+10.9%)
Sept 2019
-
-$1.89 M(-83.5%)
-$30.83 M(-16.5%)
June 2019
-
-$11.48 M(+21.6%)
-$36.90 M(-1.3%)
Mar 2019
-
-$9.44 M(+17.7%)
-$37.37 M(-7.3%)
Dec 2018
-$40.30 M
-$8.02 M(+0.7%)
-$40.30 M(-0.4%)
DateAnnualQuarterlyTTM
Sept 2018
-
-$7.96 M(-33.4%)
-$40.46 M(-1.4%)
June 2018
-
-$11.95 M(-3.4%)
-$41.02 M(+9.6%)
Mar 2018
-
-$12.37 M(+51.2%)
-$37.42 M(+14.3%)
Dec 2017
-$32.73 M(+41.5%)
-$8.18 M(-4.1%)
-$32.73 M(+4.9%)
Sept 2017
-
-$8.52 M(+2.2%)
-$31.21 M(+8.9%)
June 2017
-
-$8.34 M(+8.6%)
-$28.66 M(+7.8%)
Mar 2017
-
-$7.68 M(+15.3%)
-$26.59 M(+14.9%)
Dec 2016
-$23.13 M(+85.0%)
-$6.66 M(+11.6%)
-$23.13 M(+5.8%)
Sept 2016
-
-$5.97 M(-4.8%)
-$21.87 M(+10.0%)
June 2016
-
-$6.27 M(+48.3%)
-$19.89 M(+30.5%)
Mar 2016
-
-$4.23 M(-21.7%)
-$15.24 M(+21.9%)
Dec 2015
-$12.51 M(+121.7%)
-$5.40 M(+35.5%)
-$12.51 M(+47.0%)
Sept 2015
-
-$3.99 M(+145.5%)
-$8.51 M(+21.1%)
June 2015
-
-$1.62 M(+8.9%)
-$7.03 M(+1.8%)
Mar 2015
-
-$1.49 M(+6.3%)
-$6.90 M(+22.4%)
Dec 2014
-$5.64 M(+864.2%)
-$1.40 M(-44.1%)
-$5.64 M(+33.1%)
Sept 2014
-
-$2.51 M(+67.2%)
-$4.24 M(+145.0%)
June 2014
-
-$1.50 M(+553.7%)
-$1.73 M(+653.7%)
Mar 2014
-
-$229.50 K
-$229.50 K
Dec 2013
-$585.00 K
-
-

FAQ

  • What is Zynerba Pharmaceuticals annual earnings before interest, taxes, depreciation & amortization?
  • What is the all time high annual EBITDA for Zynerba Pharmaceuticals?
  • What is Zynerba Pharmaceuticals quarterly earnings before interest, taxes, depreciation & amortization?
  • What is the all time high quarterly EBITDA for Zynerba Pharmaceuticals?
  • What is Zynerba Pharmaceuticals TTM earnings before interest, taxes, depreciation & amortization?
  • What is the all time high TTM EBITDA for Zynerba Pharmaceuticals?

What is Zynerba Pharmaceuticals annual earnings before interest, taxes, depreciation & amortization?

The current annual EBITDA of ZYNE is -$35.03 M

What is the all time high annual EBITDA for Zynerba Pharmaceuticals?

Zynerba Pharmaceuticals all-time high annual earnings before interest, taxes, depreciation & amortization is -$585.00 K

What is Zynerba Pharmaceuticals quarterly earnings before interest, taxes, depreciation & amortization?

The current quarterly EBITDA of ZYNE is -$11.07 M

What is the all time high quarterly EBITDA for Zynerba Pharmaceuticals?

Zynerba Pharmaceuticals all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$229.50 K

What is Zynerba Pharmaceuticals TTM earnings before interest, taxes, depreciation & amortization?

The current TTM EBITDA of ZYNE is -$38.56 M

What is the all time high TTM EBITDA for Zynerba Pharmaceuticals?

Zynerba Pharmaceuticals all-time high TTM earnings before interest, taxes, depreciation & amortization is -$229.50 K